Form 8-K - Current report:
SEC Accession No. 0001829126-26-001534
Filing Date
2026-02-20
Accepted
2026-02-20 16:05:55
Documents
12
Period of Report
2026-02-16
Items
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers

Document Format Files

Seq Description Document Type Size
1 8-K kalabio_8k.htm   iXBRL 8-K 32142
  Complete submission text file 0001829126-26-001534.txt   193913

Data Files

Seq Description Document Type Size
2 XBRL SCHEMA FILE kala-20260216.xsd EX-101.SCH 2990
3 XBRL LABEL FILE kala-20260216_lab.xml EX-101.LAB 34239
4 XBRL PRESENTATION FILE kala-20260216_pre.xml EX-101.PRE 22342
14 EXTRACTED XBRL INSTANCE DOCUMENT kalabio_8k_htm.xml XML 3095
Mailing Address 1167 MASSACHUSETTS AVENUE ARLINGTON MA 02476
Business Address 1167 MASSACHUSETTS AVENUE ARLINGTON MA 02476 781-996-5252
KALA BIO, Inc. (Filer) CIK: 0001479419 (see all company filings)

EIN.: 270604595 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-38150 | Film No.: 26659831
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)